Prenatal and Newborn Genetic Testing Market

1. Prenatal and Newborn Genetic Testing Market Booming Industry Growth, Research Scope, Advance Technology and Innovations by 2030 The global Prenatal and Newborn Genetic Testing market testing was valued at ~US$ 5.3 billion in 2021. The market is expected to witness a CAGR of ~10.2% from 2022 to 2030. The growing prevalence of genetic disorders in infants such as Down syndrome, Patau syndrome, and Edwards syndrome is a key factor resulting in high demand for prenatal and newborn genetic tests. Furthermore, the uptake of such tests has further grown due to technological advancements facilitating non-invasive prenatal tests. There is also a steady increase in investments in developing genetic disorder testing and the swift adoption of such technologies in mainstream applications. Furthermore, increasing government initiatives to raise awareness about preventing congenital abnormalities is another factor driving the global prenatal and newborn genetic testing market. However, several ethical issues related to prenatal and newborn genetic testing impede the development of clinical services. Domestic governments and organizations worldwide are taking numerous initiatives to create awareness regarding the availability and accuracy of prenatal and newborn genetic testing. The initiative by the Centers for Disease Control and Prevention‘s (CDC) National Center for Environmental Health has the most successfully run public health program called Newborn Screening Quality Assurance Program, wherein all the babies born in the U.S. are screened for over 100 metabolic and genetic conditions. Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/prenatal- and-newborn-genetic-testing-market/7870 Key Players •3M Company •Align Technology, Inc. •American Prenatal and Newborn Genetic Testing •DB Prenatal and Newborn Genetic Testing Limited •Dentsply Sirona Inc. •Great Lakes Dental Technologies •Henry Schein, Inc. •Institut Straumann AG •Ormco Corporation •Morelli Orthodontia Prenatal and Newborn Genetic Testing Market by Technology •PCR •aCGH •FISH •Maternal Serum Screening •Amniocentesis By Disease •Down Syndrome •Phenylketonuria •Cystic Fibrosis

2. •Sickle Cell Anemia Key Reasons to Purchase: (1)To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape. (2)Assess the production processes, major issues, and solutions to mitigate the development risk. (3)To understand the most affecting driving and restraining forces in the Prenatal and Newborn Genetic Testing Market and its impact in the global market. (4)Learn about the market strategies that are being adopted by leading respective organizations. (5)To understand the outlook and prospects for the market. Key Questions Answered in the Report Include: (1)This report gives all the information about the industry analysis, revenue, and overview, of this market. (2)What will be the rate of increase in market size and growth rate by the end of the forecast period? (3)What are the major global Prenatal and Newborn Genetic Testing Market trends influencing the development of the market? (4)What are the vital results of SWOT analysis of the major players operating in the Prenatal and Newborn Genetic Testing Market? (5)What are the potential growth opportunities and threats faced by Major competitors in the market? TOC of Prenatal and Newborn Genetic Testing Market 1 Scope of the Report 1.1 Market Ecosystem 1.2 Geographic Scope 1.3 Timeline Under Consideration 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Prenatal and Newborn Genetic Testing Market Executive Summary 2.1 World Market Overview 2.1.1 Global Market Size 2022-2030 2.1.2 Market Size CAGR by Region 2020 VS 2028 2.2 Prenatal and Newborn Genetic Testing Market Segment by Type

3. 2.2.1 Type 1 2.2.2 Type 2 Browse the full report now: https://growthplusreports.com/report/prenatal-and-newborn-genetic- testing-market/7870 About Us Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.